Amarit Biosciences Inc is categorized under Commercial Biotechnical Research in San Mateo, CA and active since 2012.
Amarit Biosciences Inc was established in 2012, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 541711 by the NAICS.
If you are seeking more information, feel free to contact Ankush Argade at the company’s single location by writing to 281 Winchester Court, San Mateo, California CA 94404 or by phoning (650) 281-9600. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Amarit Biosciences Inc |
| Contact Person: | Ankush Argade |
| Address: | 281 Winchester Court, San Mateo, California 94404 |
| Phone Number: | (650) 281-9600 |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Founded: | 2012 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Biotechnical Research |
| SIC Code: | 8731 |
| NAICS Code: | 541711 |
| Share This Business: |
Amarit Biosciences Inc was started in 2012 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 541711. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Ankush Argade for inquiries that concern Amarit Biosciences Inc by calling the company number (650) 281-9600, as your correspondence is most welcome. Additionally, the physical location of the single location of Amarit Biosciences Inc can be found at the coordinates 37.538869,-122.275639 as well as the street address 281 Winchester Court in San Mateo, California 94404.
For its online presence, you may visit Amarit Biosciences Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.